SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-208059
Filing Date
2023-08-10
Accepted
2023-08-10 07:00:55
Documents
14
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d463183d8k.htm   iXBRL 8-K 25489
2 EX-99.1 d463183dex991.htm EX-99.1 113253
6 GRAPHIC g463183g49f79.jpg GRAPHIC 2907
  Complete submission text file 0001193125-23-208059.txt   284361

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20230810.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20230810_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20230810_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d463183d8k_htm.xml XML 3334
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 231157128
SIC: 2834 Pharmaceutical Preparations